ABC | Volume 112, Nº3, March 2019

Original Article Castro et al Troponin I after acute coronary syndrome Arq Bras Cardiol. 2019; 112(3):230-237 1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. 2. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al; ACC/AHA Task ForceMembers. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):e344-426. Erratum in: Circulation. 2014 Dec;130(25):e433-4. 3. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions. 2013 ACCF/AHA Guideline for the Management of ST-ElevationMyocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78-140. 4. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267-315. 5. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST- segment elevation: The Task Force for themanagement of acutemyocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. 6. Théroux P, Fuster V. Acute coronary syndromes: unstable angina and non- Q-wave myocardial infarction. Circulation. 1998;97(12):1195-206. 7. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327(3):146-50. 8. AntmanEM,TanasijevicMJ,ThompsonB,SchactmanM,McCabeCH,Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patientswithacutecoronarysyndromes.NEnglJMed.1996;335(18):1342-9. 9. James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, et al; GUSTO-IV-ACS Investigators. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol. 2003;41(6):916-24. 10. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000;343(16):1139-47. 11. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L, FRISC II (Fast Revascularization during InStability in CAD) Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol. 2001;38(4):979-86. 12. Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, et al. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J. 2011;161(1):68-75. Erratum in: AmHeart J. 2013;165(6):1032. 13. Ang DS, Kao MP, Dow E, Lang C, Struthers A. The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome. Heart. 2012;98(15):1160-5. 14. Goulart A, Santos IS, Sitnik D, Staniak HL, Fedeli LM, Pastore CA, et al. Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study). Clinics (Sao Paulo). 2013;68(3):431-4. 15. Santos IS, Goulart AC, Brandão RM, Santos RC, Bittencourt MS, Sitnik D, et al. One-year mortality after an acute coronary event and its clinical predictors: the ERICO study. Arq Bras Cardiol. 2015;105(1):53-64. 16. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-termmortality. Circulation. 2007;116(17):1907-14. 17. Vashistha V, Lee M, Wu YL, Kaur S, Ovbiagele B. Low glomerular filtration rate and risk of myocardial infarction: a systematic reviewandmeta-analysis. Int J Cardiol. 2016 Nov 15;223:401-9. 18. Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, et al; ExpandedGlobal Registry of Acute Coronary Events (GRACE2) Investigators. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. AmHeart J. 2009;158(2):193-201. 19. Roger VL,Weston SA, Gerber Y, Killian JM, Dunlay SM, Jaffe AS, et al. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation. 2010;121(7):863-9. 20. Nicolau JC, Franken M, Lotufo PA, Carvalho AC, Neto JA, Lima FG, et al. Use of demonstrably effective therapies in the treatment of acute coronary syndromes: comparison between different Brazilian regions. Analysis of the Brazilian Registry on Acute Coronary Syndromes (BRACE). Arq Bras Cardiol. 2012;98(4):282-9. 21. Capasso JM, Malhotra A, Li P, Zhang X, Scheuer J, Anversa P. Chronic nonocclusive coronary artery constriction impairs ventricular function, myocardial structure, and cardiac contractile protein enzyme activity in rats. Circ Res. 1992;70(1):148-62. 22. Olivetti G, Abbi R, Quaini F, Kajstura J, ChengW, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med. 1997;336(16):1131-41. 23. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57(24):2406-8. Erratum in: J Am Coll Cardiol. 2011;58(22):2356. 24. KoenigW, Breitling LP, HahmannH,Wüsten B, Brenner H, Rothenbacher D. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem. 2012;58(8):1215-24. 25. White HD, Tonkin A, Simes J, Stewart R, Mann K, Thompson P, et al; LIPID Study Investigators. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPIDStudy (Long- Term InterventionWith Pravastatin in Ischaemic Disease). J AmColl Cardiol. 2014;63(4):345-54. 26. Biener M, Giannitsis E, Kuhner M, Zelniker T, Mueller-Hennessen M, VafaieM, et al. Risk prediction in stable cardiovascular disease using a high- sensitivity cardiac troponin T single biomarker strategy compared to the ESC-SCORE. Open Heart. 2018;5(1):e000710. References Ethics approval and consent to participate This study was approved by the Ethics Committee of the Hospital Universitário da USP under the protocol number 866/08. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study. 236